Lindsey Browning
Family · Fairview, TXNPI 1396383097
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations.
Across 59 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$210
- Johnson & Johnson$121
- Supernus Pharmaceuticals, Inc.$115
- Novo Nordisk$97
- Amgen$88
- AstraZeneca$76
- plus $568 from 17 others
What the payments were for
- Food & beverage$1,275100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $210 |
| Johnson & Johnson | 1 | $121 |
| Supernus Pharmaceuticals, Inc. | 1 | $115 |
| Novo Nordisk | 5 | $97 |
| Amgen | 5 | $88 |
| AstraZeneca | 5 | $76 |
| Lilly USA, LLC | 3 | $75 |
| Vivus LLC | 3 | $56 |
| Boehringer Ingelheim | 3 | $55 |
| Pfizer | 3 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $50 |
| IBSA Pharma Inc. | 2 | $32 |
| Medtronic | 1 | $30 |
| Mylan Specialty L.p. | 1 | $30 |
| Viatris Specialty LLC | 1 | $28 |
| Corcept Therapeutics | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| GSK | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $15 |
| Tempus AI, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,275 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 28 | $230 |
| Glimepiride | 11 | $227 |
| Amlodipine Besylate | 34 | $165 |
| Montelukast Sodium | 14 | $158 |
| Levothyroxine Sodium | 21 | $140 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $137 |
| Losartan Potassium | 18 | $126 |
| Pantoprazole Sodium | 11 | $117 |
| Lisinopril | 21 | $94 |
| Hydrochlorothiazide | 18 | $81 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 12 | $67 |
| Sertraline Hcl | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other family in Fairview
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.